4DMedical

[...]   Andreas Fouras, founder and CEO, was awarded an Australian Davos Connection (ADC) Australian Leadership [...]

[...] , acknowledging the collaborative efforts and contributions to improving global healthcare of Andreas Fouras, 4Dx CEO and Founder, and Edwin Jesudason, 4Dx Director. The article pinpoints the value of [...]

[...] 4Dx founders, Andreas Fouras and Stephen Dubsky, have been independently recognised for their outstanding achievements in [...]

[...] 4Dx Founder, Andreas Fouras discussed the innovative BreathScope technology with renowned ABC science journalist and [...]

[...] 4Dx has successfully completed negotiations with Monash University for exclusive commercial use of 4DXV technology. The agreement covers three separate patents [...]

[...] imaging technology and 4Dx has successfully finalised a technology license agreement with Monash University securing the exclusive commercial rights to use this technology. A key ingredient in the [...]

[...] BreathScope. 4Dx founder and CEO, Associate Professor Andreas Fouras, PhD, has been awarded Monash University’s Vice Chancellor’s Award for Excellence in Research – Early Career [...]

[...] of 350,000 Australians each year and the escalating costs and lack of insight into these lung diseases is increasingly becoming a serious health issue. In fact Chronic Obstructive Pulmonary Disease [...]

[...] pulmonary function diagnostics and has the potential to make a difference in the diagnosis of lung diseases including lung cancer, asthma, and Chronic Obstructive Pulmonary Disease (COPD). 4Dx Founder [...]

[...] imaging methods for blood flow and tissue movement in the lungs to assist in the detection of lung diseases such as asthma, cystic fibrosis, emphysema and lung cancer. [...]

[...] and has the potential to make a difference in the diagnosis of lung diseases including lung cancer, asthma, and Chronic Obstructive Pulmonary Disease (COPD). 4Dx Founder and CEO Andreas Fouras [...]

[...] diagnostics and has the potential to assist in the diagnosis of lung diseases including lung cancer, asthma, and Chronic Obstructive Pulmonary Disease (COPD). Lung disease results in the [...]

[...] to assist in the detection of lung diseases such as asthma, cystic fibrosis, emphysema and lung cancer. [...]

[...] -dimensional X-ray imaging technique, maps the breathing lung, providing measurements of lung function at low radiation dose, highlighting the potential for such new technologies to save [...]

[...] (COPD). 4Dx Founder and CEO Andreas Fouras says “this technology will detect changes in lung function sooner, with far less radiation than a standard CT scan, and has the potential to [...]

[...] , Andreas discussed BreathScope’s new approach, which provides detailed information about lung function by directly imaging the motion of the lung. This interview can be downloaded from the ABC’s [...]

[...] three separate patents that apply across all current major target geographies. Associate Professor Andreas Fouras and his research team at the Laboratory for Dynamic Imaging in the Faculty of [...]

[...] outstanding achievements in the development of BreathScope. 4Dx founder and CEO, Associate Professor Andreas Fouras, PhD, has been awarded Monash University’s Vice Chancellor’s Award for [...]

[...] images of the lung’s shape. The technology presents an entirely new approach to pulmonary function diagnostics and has the potential to make a difference in the diagnosis of lung diseases [...]

[...] . As a Melbourne-based bio-tech company, 4Dx is taking an entirely new approach to pulmonary function diagnostics and has the potential to assist in the diagnosis of lung diseases including lung [...]

[...] . Associate Professor Andreas Fouras and his research team at the Laboratory for Dynamic Imaging in the Faculty of Engineering at Monash University developed a technology which [...]

[...] researcher Associate Professor Andreas Fouras and his research team at the Laboratory for Dynamic Imaging in the Faculty of Engineering have developed a revolutionary lung imaging technology and 4Dx [...]

[...] A 4Dx image taken as part of product testing is featured in the launch of the Zyla sCMOS HF camera. 4Dx was recently approached by Andor Technology Ltd to test the use of its new product [...]

[...] lung cancer, asthma, and Chronic Obstructive Pulmonary Disease (COPD). 4Dx Founder and CEO Andreas Fouras says “this technology will detect changes in lung function sooner, with far less [...]